Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I gene
Dyk ned i forskningsemnerne om 'Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I gene'. Sammen danner de et unikt fingeraftryk.
Keyphrases
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science